Nigeria recorded a significant spike in its daily fatality
toll on Tuesday as 31 persons were confirmed to have died of COVID-19
complications.
A total of 455 COVID-19 deaths have now been recorded in the
country.
According to the update by the Nigeria Centre for Disease
Control (NCDC) for June 16, 2020, the 31 deaths included 25 fatalities which
occurred in Lagos between Friday and Monday, but were announced on Tuesday.
In the data released at the stroke of midnight on Tuesday,
the agency also confirmed 490 new COVID-19 cases in 15 states and the federal
capital territory (FCT).
While Lagos had 142 new cases and FCT recorded 60 cases,
Bayelsa confirmed its highest daily toll with 54 cases, increasing the state’s
figures from 32 to 86.
Bayelsa has now moved 11 spots upwards from being the fourth
state with the least number of cases; it is now the 22nd state with the most
COVID-19 cases in the country.
However, a record total of 274 persons were discharged on
Tuesday, increasing the number of recoveries from 5,349 to 5,623.
A total of 17,148 cases have now been confirmed in 35 states
and the FCT.
490 new cases of #COVID19Nigeria;— NCDC (@NCDCgov) June 16, 2020
Lagos-142
FCT-60
Bayelsa-54
Rivers-39
Delta-37
Oyo-30
Kaduna-26
Imo-23
Enugu-19
Kwara-17
Gombe-11
Ondo-10
Bauchi-8
Ogun-7
Borno-6
Benue-1
17,148 confirmed
5,623 discharged
455 deaths pic.twitter.com/wou7Q1PfIo
Earlier on Tuesday, a team of medical researchers from
Oxford University announced results of a drug trial involving dexamethasone, a
widely available steroid, which they said could help high-risk COVID-19
patients recover fast.
However, a statement issued by the NCDC later on Tuesday,
emphasised that while there will be further research to determine the efficacy
of the drug trials on COVID-19 treatment, the federal government has not
approved any treatment for coronavirus disease.
“The Nigeria Centre for Disease Control (NCDC) is aware of
recent outcomes from a UK-Government funded clinical trial for COVID-19. The
results support the use of Dexamethsaone as a possible treatment to reduce the
risk of death among COVID-19 patients, who require oxygen or mechanical
ventilation,” it read.
“Please note that the Government of Nigeria has not
validated or approved any treatment for COVID-19. In addition, the use of
Dexamethasone for COVID-19 treatment has not been validated by WHO.
“We are aware of ongoing clinical trials conducted by
scientists in the UK and will work with our sister agencies to evaluate this
emerging data on the use of Dexamethasone. We will inform the general public on
outcomes following scientific review and validation.”
Click to signup for FREE news updates, latest information and hottest gists everyday
Advertise on NigerianEye.com to reach thousands of our daily users
No comments
Post a Comment
Kindly drop a comment below.
(Comments are moderated. Clean comments will be approved immediately)
Advert Enquires - Reach out to us at NigerianEye@gmail.com